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1. Introduction 
Today, cancer had been described as one of the 
deadliest diseases worldwide. It has been estimated that 
cancer causes about 9.9 million deaths in the year 2020 [1]. 
Cancer is a complex disease characterized by uncontrolled 
proliferation and development of cells in tissues forming 
a tumour that may potentially expand to a whole organ 
or systematically to other tissues called metastasis [2]. 
The severity of death due to cancer in the world every 
year indicated that the present standard of treatment with 
chemotherapeutic drugs is not enough. According to the 
World Health Organization (WHO), the global cancer 
rate could increase by half by 2020 in which majority 
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Today, cancer had been described as one of the deadliest diseases 
worldwide. It has been estimated that cancer causes about 9.9 million 
deaths in the year 2020. The conventional treatment for the disease 
involves single chemotherapy or a combination of mono-chemotherapy and 
or a combination of mono-chemotherapy and radiotherapy. However, there 
are negative sides to these approaches which have prompted the search for 
new therapeutic drugs. In view of this, scientific communities have started 
looking for innovative sources of anticancer compound of natural origin 
which include traditional plants. Nowadays, several studies have evaluated 
the anticancer properties of bioactive components (phytochemicals) 
derived from the plants both in vivo and in vitro. The phytochemicals are 
secondary metabolites or chemical compound produced during metabolic 
process in plants which are useful in the protection of plants. Most of 
these phytochemicals such as alkaloid, flavonoids, phenolic compounds, 
cyanidin, fisetin, genistein, gingerol kaempferol, quercetin, resveratrol 
possessed certain medicinal properties and found to have numerous 
applications in pharmaceutical industries for treatment of cancer. The paper 
was aimed to review some plants bioactive components (phytochemicals) 
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of the affected population will be from medium and low 
income countries, with lack of chemotherapeutic drugs 
as well as other resources [3]. As result, there is need 
for alternative anticancer therapeutic drugs. This has 
pushed researchers and scientist to search for innovative 
alternate source of anticancer drugs from natural source 
including plants [4]. Initially, plants have been used in all 
cultures for healing wide ranges of diseases and as well 
to improve well-being [5,6]. Further studies demonstrated 
that medicinal plants contain secondary metabolites called 
phytochemicals, which have a positive effect on health 
due to their medicinal properties. These effects of the 
phytochemicals are attributed to the biological properties 
such as anti-inflammatory, antioxidant, antimicrobial and 
anticancer they possessed. Today, the potential of plants 
as a source of anticancer agents is recorded well both 
in experimental findings and traditional medicine [7]. In 
most cases, phytochemicals have been applied directly or 
modified chemically to develop chemical compounds used 
in modern medicine which include anticancer drugs. Food 
and Drug Administration (FDA) inform that over 60% of 
the drugs used in treatment of cancer are sourced from 
natural resources [5].
Therefore, plant-anticancer compound has been 
considered as a possible option for the development 
of new chemotherapeutics and also to improve the 
affectivity of the conventional drugs [8-10]. However, these 
plants derived compounds present many drawbacks, 
such as negative side effect (toxicity), low stability and 
difficulties in extraction from natural source [11]. Hence, 
the application of phytochemicals still faces challenges 
and need for further research is vital. Phytochemicals are 
largely distributed in different parts of plants with the 
potential of reducing the risk of different types of diseases 
including cancer [12].
2. Cancer 
Today, cancer had been described as one of the 
deadliest diseases worldwide. It has been estimated 
that cancer causes about 9.9 million deaths in the year 
2020 [1]. Cancer is a complex disease characterized by 
uncontrolled proliferation and development of cells in 
tissues forming a tumour that may potentially expand to 
a whole organ or systematically to other tissues called 
metastasis [2]. The abnormal cell behavior due to cancer 
may be as a result of heredity genetics or alteration of 
oncogens related to cell cycle and regulation of cell death 
(apostasis) [13]. According to World Health Organization, 
the main causes behind the development of cancer 
include; ionization radiation, reactive oxidative species 
(ROS), random somatic mutation, chemical agents 
such as alkylating agents, and biological agents [14]. The 
ionization radiations such as x-rays are able to disrupt 
the hydrogen bond between nucleic acid thereby altering 
its chemical structure, which may lead to alteration in 
normal DNA expression regulation [15]. Infectious caused 
by microorganisms such as bacteria, virus and fungi have 
also been significantly correlated with developing cancer 
[16]. Virus that integrate their genetic materials into the 
host tissue or organ may alter normal genetic expression 
related to cell division or even induce oncogens that could 
derive into cancer development [17-19]. Conversely, bacterial 
infection may evoke the release of toxins with cytotoxic 
effect and the disruption of the tissue cell matrix. Some 
common examples of bacterial toxins are enteric toxins 
from Salmonella typhi or CagA and vacuolating toxins 
of Helicobacter pylori, which may induce formation of 
new tissue (neoplasia), cell death, and alteration in the 
normal cell metabolism [20,21]. Other infectious pathogens 
such as parasitic helminths and fungi that produce direct 
or toxin-mediated tisular damage are also considered as 
oncogenic agents [22]. Apart from genetic alteration, the 
main recognized tumor-inducing mechanism of biological 
agents is tissue inflammation as a result of cell damage 
and subsequent neoplasia which, if unchecked, can result 
in potential chronic inflammation of the affected tissues 
(e.g., hepatic cirrhosis by Hepatitis virus) [17,23].
Reactive oxygen species (ROS) such as hydroxyl 
radical or hydrogen peroxide are believed to provoke the 
alteration and damage of the cell membrane, DNA and 
lipids [24]. They are also been identified to increase in tumor 
cells enhancing their survivability and proliferation [25]. 
Nonetheless, the common factor besides possible genetic 
alterations by oxidative stress, infections and ultraviolet 
radiation is the associated inflammatory response [22,24]. 
On this matter, chronic inflammation is considered both 
cause and symptom of other ailments, but particularly of 
cancer, as tumorous cells secrete several pro-inflammatory 
molecules [26]. For example, it is well known that the 
pro-inflammatory mediator cyclooxygenase-2 (COX-
2) is over-expressed in several types of cancer. As such, 
pro-inflammatory mediators are markers of cancer and 
could be also a possible target for anticancer therapies 
[27,28]. Considering chemical carcinogens aside from 
potentially hazardous substances, the main carcinogens 
originate in diet. Major chemical carcinogens include 
polycyclic aromatic hydrocarbons (PAHs), N-nitroso 
compounds, heterocyclic amines (HCAs) and alcohol. 
PAHs like anthracene appear in combustion reactions, 
and are reported in grilled or smoked foods, as well as 
being part of urban air pollution. They are linked to lung 
and digestive tract cancer [29,30]. Closely related in their 
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effects and occurrence, HCAs like 2-Amino-1-methyl-6-
phenylimidazo [4,5-b] pyridine are the result of pyrolysis 
of proteins and amino acids in meat or fish foods [31,32]. It 
is worth mentioning that tobacco is reported to contain 
high levels of PAHs and HCAs, linking them to the pro-
carcinogen effects of tobacco consumption [33]. N-nitroso 
compounds are additives in processed meats and include 
nitrites and nitrosamines like N-nitrosedimethylamine that 
have been correlated to gastric cancer development [34]. 
Ethanol as well as other alcohols present in beverages and 
spirits induce many metabolic and endocrine disorders 
along with being highly cytotoxic chemicals and attributed 
to cause many types of cancers [35]. Altogether, it should be 
considered that a variety of exogenous carcinogens from 
different sources can heavily prompt cancer development
3. Phytochemicals
The phytochemicals are secondary metabolites or 
chemical compound produced during metabolic process 
in plants which are useful in the protection of plants 
[37]. Many of these secondary metabolites possess vital 
medicinal properties which have many applications 
in pharmaceutical industries. Phytochemicals such as 
alkaloids, tannin, quinones, flavonoids, vitamins and 
amines are free radical-scavenging molecules and 
possess antimicrobial, anti-inflammatory, antioxidant and 
anticancer activities [38]. In general, most plants bioactive 
components possess antioxidant property which protects 
human cells against oxidative damage. Phytochemical 
from such plants are used for reducing the intensity 
of inflammation related diseases and as well provide 
protective effect by countering reactive oxygen species 
(ROS) [39].
4. Some Phytochemicals Used as Anticancer 
Agents
4.1 Cyanidin
Cyanidin is an extract of pigment from red berries 
such as blackberry, apples, red onion, red cabbage, plums, 
raspberry, cranberry and grapes. The extract possesses 
radical scavenging and antioxidant effect which may 
reduce cancer risk. It is reported that cyanidin inhibits 
cell proliferation and gene expression in colon cancer 
cell [40]. Another research demonstrated that Cyanidin-
3-glucoside (C3G) attenuated the benzo[a]pyrene-7,8-
diol-9,10-epoxide-induced activation of AP-1 and NF-κB 
and phosphorylation of MEK, MKK4, Akt, and MAPKs 
and blocked the activation of the Fyn kinase signaling 
pathway, which may contribute to its chemo-preventive 
potential [41]. Cyanidin-3-glucoside inhibit ethanol-
induced activation of ErbB2/cSrc/FAK pathway in breast 
cancer cells and may reduce ethanol-induced breast 
cancer metastasis [42], inhibition of growth and induction 
of apostasis in tumorigenic rat esophagus cell line [43], and 
inhibition of UVB-induced COX-2 expression and PGE2 
secretion in the epidermal skin cell line by suppressing 
NF-κB and AP-1 which are regulated by MAPK [44-46].
4.2 Fisetin 
Fisetin is the flanone found in several plants such 
as Eurasian smoke tree, apple, grape, onion, Acacia, 
cucumber, strawberries, and persimmon [47].  The 
compound has been found to reduce aging effect in 
fruit fly or yeast [48] and exert anti-inflammatory effect 
in LPS-induced acute pulmonary inflammation and 
anticarcinogenic effects in HCT-116 human colon 
cancer cells [49]. Fisetin is also a potent antioxidant and 
modulates lipid and protein kinase pathways. Along with 
other flavonoids such as luteolin, galangin, quercetin and 
EGCG, induced the expression of Nrf2 and the phase 
II gene product HO-1 in retinal pigment epithelial cells 
which could retinal pigment epithelial cells from death 
due to oxidative stress with high degree of potency and 
low toxicity and reduced hydrogen peroxide induced cell 
death. A study conducted by Khan et al. [50] found dual 
inhibition of PI3K/Akt and mTOR signaling in human 
non-small cell lung cancer cells by fisetin.
4.3 Genistein
Genistein is the isoflavane that originate from a 
number of plants such as fava beans, lupine, soy beans, 
coffee, Flemingia vestita and kudzu. Genistein functions 
as anthelmintic, antioxidant and as well found to have 
antiangiogenic effect i.e. blocking of blood vessels 
formation. It also found to block the uncontrolled cell 
growth associated with cancer most likely by inhibiting 
the enzyme that regulate cell survival (growth factor) and 
cell division. The genistein activity was actively functions 
as tyrosine inhibitor by inhibiting DNA topoisomerase 
II [51]. In vivo and in vitro studies show that genistein is 
important in treating leukemia [52]. 
4.4 Gingerol
Gingerol is an active component of fresh ginger with 
characteristics spiciness. It is known for its anticancer 
activity against cancer in the colon [53], ovary, breast 
[54], and pancrease [55]. A review recently conducted by 
Oyagbemi et al. [56] summed up the mechanisms in the 
medicinal effect of gingerol. In summary, gingerol has 
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demonstrated anti-inflammatory, antioxidant and antitumor 
promoting properties and decreases iNOS and TNF-alpha 
expression via suppression of IκBα phosphorylation and 
NF-κB nuclear translocation [56]. Treating MOLT4 and 
K562 with gingerol, the ROS level was significantly 
higher than the control, including apoptosis of leukemia 
cells by mitochondrial pathway. 
4.5 Kaempferol
Kaempferol is a natural flavonol isolated from grape 
fruit, apples, tea, witch hazel, Brussels sprout brococoli 
etc. it has been studied for pancreatic cancer [57] and lung 
cancer [58]. Kaempferol has also been investigated for its 
radical scavenging effect, antiangiogenic and anticancer 
[59]. The compound displayed moderate cytostatic activity 
of 24.8 - 64.7µM in the cell line of PC3, HeLa, and K562 
human cancer cell. Kaempferol has been studied as aryl 
hydrocarbon receptor antagonist showing inhibition of 
ABCG2upregulation, thereby reversing the ABCG2-
mediated multidrug resistance and this can be useful for 
treatment of esophageal cancer. 
4.6 Lycopene
Lycopene as phytochemical is a bright red pigment 
from fruits such as watermelons, tomato, red papayas 
and red carrot. It shows antioxidant activity and chemo-
preventive effect in prostate cancer. The anticancer 
property of lycopene is largely attributed to activating 
cancer preventing enzymes such as phase II detoxification 
enzymes [60]. Lycopene was found inhibiting human cancer 
cell proliferation and suppressing insulin like growth 
factor-I-stimulated growth. This may open new avenue 
for its study on the role of the treatment and prevention 
of endometrial cancer and other forms of tumors. The 
Lycopene also possessed inhibitory effects on endometrial 
and breast cancer cell [61], prostate and colon cancer cells 
[60].
4.7 Quercetin
Quercetin is a flavonoid compound mostly found 
in leafy vegetables, berries and onions, to which the 
anticancer property is attributed [62]. In this sense, 
numerous studies in vivo and in vitro pre-clinical studies 
have shown positive results. Regarding its action 
mechanisms, quercetin has been demonstrated to induce 
cell cycle arrest by regulating cyclin D1 and p53-related 
pathways; apoptosis trough the induction of pro-apoptotic 
factors and the decrease of anti-apoptotic ones; induces 
autophagy and inhibits proliferation, angiogenesis and 
metastasis [63]. These effects have been observed in 
different in vitro cell lines, including breast, ovarian, 
lung and colon cancer cells, among many others [63], and 
also in different in vivo mice models [64]. Furthermore, 
quercetin has been reported to enhance the efficacy of 
chemotherapeutic drugs [65]. Regarding clinical trials, 
several have evaluated the suitability of quercetin as 
anticancer drug. For example, a study conducted on 
humans reported that a high intake of quercetin in the diet 
is inversely related to the risk of gastric adenocarcinoma 
[66]. Another study evaluated the use of quercetin to 
prevent and treat oral mucositis induced by chemotherapy. 
The results showed a significant reduction of oral 
mucositis incidence in the quercetin treated group, which 
may suggest that this compound could be used to palliate 
chemotherapy side-effects [67]. 
4.8 Resveratrol
Resveratrol is a phenolic compound present in 
some fruits, such as grapes, peanuts, blueberries and 
blackberries. Numerous studies have evaluated the 
anticancer properties of this compound. Several action 
mechanisms of resveratrol have been described: positive 
regulation of p53 and BAX proteins (related with pro-
apoptotic pathways) and negative regulation of NF-_
B, AP-1, hypoxia-inducible factor 1-alpha (HIF-1_), 
matrix metalloproteases, Bcl-2 protein, COX-2, cytokines 
and CDK [68]. Some pre-clinical studies performed in 
vitro demonstrated that resveratrol was able to suppress 
the cell proliferation through cell cycle arrest, induce 
apoptosis and modulate autophagy in different cancer cell 
lines, including ovarian cancer cell line, resistant human 
leukemia cells, non-small-cell lung cancer and human 
lung adenocarcinoma [69]. Regarding in vivo studies, 
the anticancer properties of these compounds were also 
significant. For example, in an in vivo study, resveratrol 
was administered to mice, leading to a 60% reduction in 
the appearance of sporadic colorectal cancer. Similarly, 
resveratrol inhibited cell proliferation, induced the 
apoptosis and suppressed the angiogenesis and metastasis 
in bladder cancer mice models [70]. Resveratrol has 
been also reported to enhance the efficacy of traditional 
chemotherapeutic drugs, including temozolomide, 
doxorubicin and paclitaxel in mice models [71].
5. Conclusions
Cancer is a complex disease that every year costs 
several millions of human lives. The uncontrolled 
proliferation of cells causes the incorrect functioning 
of the body, with a long list of symptoms and finally, 
death. So, given the health and social importance 
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of this disease, but also its economic impact on the 
health system, new therapeutic alternatives are being 
continuously investigated. Traditional plants have been 
historically considered as an endless source of new 
compounds for the development of new pharmaceuticals 
and drugs. Therefore, nowadays researchers have at 
their complete disposal, plenty of ethnomedicinal and 
ethnopharmacological information of very different 
plant species which is a tool for selecting candidates and 
lead the research to those plants more promising. In this 
context, a variety of phytochemicals obtained from plants 
have been discovered and are currently used in cancer 
therapies such as cyanidin, fisetin, genistein, gingerol 
kaempferol, quercetin, resveratrol. 
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